Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sparano

Showing results (541-550 of 560) with videos related to

Pageof 56
Sort By:
Medrxiv : the Preprint Server for Health Sciences|May 25, 2026
Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer RecurrenceNgoc-Kim Nguyen, Anran Li, Sara Kochanny, et al.
Endocrine-Related Cancer|March 17, 2023
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE studyNicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
JAMA Oncology|October 1, 2019
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical TrialJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Journal of the National Cancer Institute|September 28, 2020
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx TrialKathy S Albain, Robert J Gray, Della F Makower, et al.
JCO Oncology Advances|May 18, 2026
Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 TrialMoriah Forster, Fengmin Zhao, Sarah Bell, et al.
Thyroid : Official Journal of the American Thyroid Association|September 19, 2023
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune ThyroiditisSimone De Leo, Silvia D'Elia, Giorgio Grani, et al.
The New England Journal of Medicine|June 4, 2019
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast CancerJoseph A Sparano, Robert J Gray, Peter M Ravdin, et al.
The Journal of Clinical Endocrinology and Metabolism|February 16, 2023
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter StudyGiorgio Grani, Michele Gentili, Federico Siciliano, et al.
The New England Journal of Medicine|June 15, 2022
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal CancerJoel M Palefsky, Jeannette Y Lee, Naomi Jay, et al.
The New England Journal of Medicine|September 29, 2015
Prospective Validation of a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Pageof 56

Showing results (541-550 of 560) with videos related to

Sort By:
Pageof 56
Medrxiv : the Preprint Server for Health Sciences|May 25, 2026
Development and Validation of a Multimodal Clinical, Pathologic, and Genomic Model for Breast Cancer RecurrenceNgoc-Kim Nguyen, Anran Li, Sara Kochanny, et al.
Endocrine-Related Cancer|March 17, 2023
COVID-19 in patients with neuroendocrine neoplasms: 2-year results of the INTENSIVE studyNicola Fazio, Lorenzo Gervaso, Thorvardur R Halfdanarson, et al.
JAMA Oncology|October 1, 2019
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy: A Secondary Analysis of the TAILORx Randomized Clinical TrialJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Journal of the National Cancer Institute|September 28, 2020
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx TrialKathy S Albain, Robert J Gray, Della F Makower, et al.
JCO Oncology Advances|May 18, 2026
Impact of Race, Socioeconomic Status, and Clinicopathologic Features on Clinical Outcomes in Triple-Negative Breast Cancer in the ECOG-ACRIN EA1131 TrialMoriah Forster, Fengmin Zhao, Sarah Bell, et al.
Thyroid : Official Journal of the American Thyroid Association|September 19, 2023
A Prospective Multicenter Study Examining the Relationship Between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune ThyroiditisSimone De Leo, Silvia D'Elia, Giorgio Grani, et al.
The New England Journal of Medicine|June 4, 2019
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast CancerJoseph A Sparano, Robert J Gray, Peter M Ravdin, et al.
The Journal of Clinical Endocrinology and Metabolism|February 16, 2023
A Data-Driven Approach to Refine Predictions of Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter StudyGiorgio Grani, Michele Gentili, Federico Siciliano, et al.
The New England Journal of Medicine|June 15, 2022
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal CancerJoel M Palefsky, Jeannette Y Lee, Naomi Jay, et al.
The New England Journal of Medicine|September 29, 2015
Prospective Validation of a 21-Gene Expression Assay in Breast CancerJoseph A Sparano, Robert J Gray, Della F Makower, et al.
Pageof 56